FOR BIOTECH BD TEAMS
Enterprise competitive intel without enterprise pricing
Know what your competitors are doing—without a $50K Evaluate subscription or hours on ClinicalTrials.gov.
Sound familiar?
"Your CEO just asked who else is targeting the same mechanism. You could spend $50K on Evaluate, or 3 hours on ClinicalTrials.gov. Neither works when you need an answer in 30 minutes."
The Enterprise Problem
- $50K+ subscriptions need procurement approval
- Months of vendor security reviews
- Tools designed for 100+ seat deployments
- You just need competitive intelligence now
The TheraRadar Way
- Expense without procurement
- Start using in 5 minutes
- Built for small, fast-moving teams
- 80% of what you need at 5% of the price
Real BD Use Cases
Questions you answer every week—answered faster
Monitor Competitor Pipelines
"CEO asks: "Who else is targeting our mechanism?""
Prepare for Partnering Meetings
"Meeting with Big Pharma BD next week"
Scout Licensing Targets
"Find Phase 2 assets from small biotechs"
Board Competitive Update
"Quarterly update on competitive landscape"
Compare the Cost
| Tool | Price | Pros | Cons |
|---|---|---|---|
| Evaluate Pharma | $50K+/yr | Comprehensive | Enterprise sales, slow onboarding |
| Citeline | $30K+/yr | Deep trial data | Complex interface, learning curve |
| BCIQ | $15K+/yr | Deal terms data | Focus on financing, not pipelines |
| TheraRadar | Free – $49/mo | Fast, simple, self-serve | US-focused, no deal terms |
Built for BD Teams
Target Landscapes
See every drug targeting the same protein as yours
Pipeline Comparison
Side-by-side view of competitor development stages
Real-time Alerts
Know when competitors advance to the next phase
PDUFA Calendar
Track FDA decision dates for your competitive set